title: Nitric oxide synthase inhibition restores hypoxic pulmonary vasoconstriction in sepsis.
abstract: Hypoxic pulmonary vasoconstriction (HPV) is inhibited by inhaled nitric oxide (NO) in healthy animals and is blunted in endotoxemia. We investigated whether the loss of HPV during sepsis could be reversed by NO synthase (NOS) inhibition. Hypoxic challenges were induced in intubated, awake sheep breathing 100% nitrogen to the left lung and 100% oxygen to the right lung. HPV was assessed as the decrease in left pulmonary blood flow during hypoxia, measured with an ultrasonic flow probe around the left pulmonary artery. Group I (n = 5) received carrier solutions and Groups II (n = 6) and III (n = 8) received an infusion containing Pseudomonas aeruginosa. After 24 h, Group III also received an infusion of 6.6 mg.kg.h-1 N omega-monomethyl-L-arginine (L-NMMA). After 24 h of sepsis, HPV decreased from 60 +/- 9% in Group II and 56 +/- 4% in Group III to 27 +/- 2% and 26 +/- 4%, respectively. Group I showed no change in HPV. During infusion of L-NMMA, HPV increased to 38 +/- 4%. Pulmonary shunt during hypoxia increased in Group III to 161 +/- 10% of its baseline value, and decreased to 121 +/- 11% during infusion of L-NMMA. We conclude that L-NMMA improves but does not restore HPV, indicating that other vasodilatory mediators besides NO also influence HPV in sepsis.
authors.affiliation: Department of Anesthesiology, University of Texas Medical Branch, Galveston 77555-0833, USA.
authors.forename: S R
authors.initials: SR
authors.lastname: Fischer
authors.forename: D J
authors.initials: DJ
authors.lastname: Deyo
authors.forename: H G
authors.initials: HG
authors.lastname: Bone
authors.forename: R
authors.initials: R
authors.lastname: McGuire
authors.forename: L D
authors.initials: LD
authors.lastname: Traber
authors.forename: D L
authors.initials: DL
authors.lastname: Traber
mesh_terms: D000818:Animals; D003251:Constriction, Pathologic / Q000000981:diagnostic imaging / Q000382:microbiology; D004195:Disease Models, Animal; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D000860:Hypoxia / Q000000981:diagnostic imaging / Q000382:microbiology*; D009569:Nitric Oxide / Q000502:physiology; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*; D011552:Pseudomonas Infections / Q000150:complications*; D011651:Pulmonary Artery / Q000187:drug effects*; D011652:Pulmonary Circulation / Q000187:drug effects; D011669:Pulmonary Wedge Pressure / Q000187:drug effects; D018805:Sepsis / Q000150:complications*; D012756:Sheep; D014463:Ultrasonography; D019323:omega-N-Methylarginine / Q000494:pharmacology*
chemical_list: D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase